Imaging artifacts of liquid embolic agents on conventional CT in an experimental in vitro model
BACKGROUND AND PURPOSE: Endovascular embolization using liquid embolic agents is
a safe and effective treatment option for AVMs and dural arteriovenous fistulas. The aim of …
a safe and effective treatment option for AVMs and dural arteriovenous fistulas. The aim of …
Imaging artifacts of nonadhesive liquid embolic agents in conventional and cone-beam CT in a novel in vitro AVM model
Background A major drawback of liquid embolic agents (LEAs) is the generation of imaging
artifacts (IA), which may represent a crucial obstacle for the detection of periprocedural …
artifacts (IA), which may represent a crucial obstacle for the detection of periprocedural …
Beam hardening artifacts of liquid embolic agents: comparison between Squid and Onyx
R Pop, L Mertz, A Ilyes, D Mihoc, JS Richter… - Journal of …, 2019 - jnis.bmj.com
Background Initial clinical experience with Squid shows subjectively reduced artifacts on
post-embolization CT scans compared with Onyx. To further investigate these observations …
post-embolization CT scans compared with Onyx. To further investigate these observations …
Glue, Onyx, Squid or PHIL? Liquid embolic agents for the embolization of cerebral arteriovenous malformations and dural arteriovenous fistulas
DF Vollherbst, R Chapot, M Bendszus… - Clinical …, 2022 - Springer
Background Endovascular embolization is an effective treatment option for cerebral
arteriovenous malformations (AVMs) and dural arteriovenous fistulas (DAVFs). A variety of …
arteriovenous malformations (AVMs) and dural arteriovenous fistulas (DAVFs). A variety of …
Imaging artifacts of Onyx and PHIL on conventional CT, cone-beam CT and MRI in an animal model
DF Vollherbst, R Otto, T Do… - Interventional …, 2018 - journals.sagepub.com
Background and purpose A frequently reported drawback of ethylene vinyl alcohol
copolymer-based liquid embolic agents is the production of artifacts in diagnostic imaging …
copolymer-based liquid embolic agents is the production of artifacts in diagnostic imaging …
Visibility of liquid embolic agents in fluoroscopy: a systematic in vitro study
N Schmitt, L Wucherpfennig, S Hohenstatt… - Journal of …, 2023 - jnis.bmj.com
Background Endovascular embolization using liquid embolic agents (LEAs) is frequently
applied for the treatment of intracranial vascular malformations. Appropriate visibility of LEAs …
applied for the treatment of intracranial vascular malformations. Appropriate visibility of LEAs …
Preliminary experience with the liquid embolic material agent PHIL (Precipitating Hydrophobic Injectable Liquid) in treating cranial and spinal dural arteriovenous …
JJ Leyon, S Chavda, A Thomas, S Lamin - Journal of …, 2016 - jnis.bmj.com
Background Liquid embolic agents are the preferred embolic material in endovascular
treatment of pial and brain arteriovenous malformations and dural arteriovenous fistulas …
treatment of pial and brain arteriovenous malformations and dural arteriovenous fistulas …
Embolization of intracranial dural arteriovenous fistulas using PHIL liquid embolic agent in 26 patients: a multicenter study
S Lamin, HS Chew, S Chavda… - American Journal …, 2017 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: The introduction of liquid embolic agents has
revolutionized endovascular approach to cranial vascular malformations. The aim of the …
revolutionized endovascular approach to cranial vascular malformations. The aim of the …
Intermixed Dimethyl-Sulfoxide–Based Nonadhesive Liquid Embolic Agents Delivered Serially via the Same Microcatheter for Cerebral AVM Treatment
A Sirakov, K Minkin, S Sirakov - American Journal of …, 2020 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Conventional nonadhesive liquid embolic agents currently
are the criterion standard for endovascular embolization of cerebral AVMs. However …
are the criterion standard for endovascular embolization of cerebral AVMs. However …
The impact of software-based metal artifact reduction on the liquid embolic agent Onyx in cone-beam CT: a systematic in vitro and in vivo study
N Schmitt, CS Weyland, L Wucherpfennig… - Journal of …, 2022 - jnis.bmj.com
Background Onyx is frequently used for endovascular embolization of intracranial
arteriovenous malformations (AVMs) and dural arteriovenous fistulas (dAVFs). One …
arteriovenous malformations (AVMs) and dural arteriovenous fistulas (dAVFs). One …
